Literature DB >> 23543194

Molecular mechanisms involved in the protective effect of the chloroform extract of Selaginella lepidophylla (Hook. et Grev.) Spring in a lithiasic rat model.

Estévez-Carmona María Mirian1, Narvaéz-Morales Juanita, Barbier Olivier Christophe, Meléndez-Camargo María Estela.   

Abstract

Urolithiasis is a multifaceted process, progressing from urine supersaturation to the formation of mature renal calculi. Calcium oxalate, the main component of kidney stones, has toxicological effects on renal epithelial cells. Some medicinal plants have shown pharmacological effects against renal lithiasis, such as Selaginella lepidophylla (Hook. et Grev) Spring, a plant empirically used in Mexico for its diuretic and antilithiasic activity. The plant was identified and ground, and a chloroform extract (CE) was obtained. Urolithiasis was induced in Wistar female rats by administration of ethylene glycol and ammonium chloride for 21 days. Urolithiasis rats were treated with the CE (50 mg/kg) for 21 days. Osmolality, creatinine, sodium and potassium concentrations were measured in blood and urine. Glomerular filtration rate (GFR), and electrolytic and water balances were calculated. Urinary oxalic acid concentration was measured. Apoptosis, lipoperoxidation, ROS and p-amino hippuric acid were determined in cortical tissue. Urolithiasis rats showed a decrease of urinary flow, GFR, electrolytic balance, renal tubular secretion and ATP concentration and increase of urinary oxalic acid, lipoperoxidation, oxidative stress and apoptosis in cortical tissue. After treatment with the CE, urinary flow rate, GFR and renal tubular secretion levels were recovered; on the other hand, serum creatinine and urinary oxalic acid decreased on day 21. CE of Selaginella lepidophylla prevented the damage caused by lithiasic process by improving the active secretion in the proximal tubules, counteracting the ROS and lipoperoxidation effects by oxalate and decreased the OAT3 expression on kidney.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543194     DOI: 10.1007/s00240-013-0556-9

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  47 in total

Review 1.  Oxalate transport and calcium oxalate renal stone disease.

Authors:  C F Verkoelen; J C Romijn
Journal:  Urol Res       Date:  1996

Review 2.  Medical management of urolithiasis, what opportunity for phytotherapy?

Authors:  Fouad Atmani
Journal:  Front Biosci       Date:  2003-05-01

3.  Diuretic effect of the aqueous extract of Bidens odorata in the rat.

Authors:  Ma Estela Meléndez Camargo; Blanca Berdeja; Guadalupe Miranda
Journal:  J Ethnopharmacol       Date:  2004-12       Impact factor: 4.360

Review 4.  Kidney stones: pathophysiology and medical management.

Authors:  Orson W Moe
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

5.  Hypothyroidism maintained reactive oxygen species-steady state in the kidney of rats intoxicated with ethylene glycol: effect related to an increase in the glutathione that maintains the redox environment.

Authors:  María Mirian Estévez-Carmona; Estela Meléndez-Camargo; Rocio Ortiz-Butron; Marisol Pineda-Reynoso; Margarita Franco-Colin; Edgar Cano-Europa
Journal:  Toxicol Ind Health       Date:  2012-04-04       Impact factor: 2.273

6.  Apoptosis induced by oxalate in human renal tubular epithelial HK-2 cells.

Authors:  Byong-Chang Jeong; Cheol Kwak; Kyu Seon Cho; Bong Sub Kim; Sung Kyu Hong; Jung-In Kim; Chongwook Lee; Hyeon Hoe Kim
Journal:  Urol Res       Date:  2005-03-10

7.  Life-threatening complication after extracorporeal shock wave lithotripsy for a renal stone: a hepatic subcapsular hematoma.

Authors:  Tae-Beom Kim; Ho-Ki Park; Kwang-Yeom Lee; Khae-Hawn Kim; Han Jung; Sang-Jin Yoon
Journal:  Korean J Urol       Date:  2010-03-19

8.  Expression and function of Oat1 and Oat3 in rat kidney exposed to mercuric chloride.

Authors:  Gisela Di Giusto; Naohiko Anzai; María L Ruiz; Hitoshi Endou; Adriana M Torres
Journal:  Arch Toxicol       Date:  2009-06-17       Impact factor: 5.153

9.  An aqueous extract of Ammi visnaga fruits and its constituents khellin and visnagin prevent cell damage caused by oxalate in renal epithelial cells.

Authors:  P Vanachayangkul; K Byer; S Khan; V Butterweck
Journal:  Phytomedicine       Date:  2009-12-29       Impact factor: 5.340

10.  Antiurolithic activity of Origanum vulgare is mediated through multiple pathways.

Authors:  Aslam Khan; Samra Bashir; Saeed R Khan; Anwar H Gilani
Journal:  BMC Complement Altern Med       Date:  2011-10-17       Impact factor: 3.659

View more
  4 in total

1.  Neuroprotective effect of aqueous extract of Selaginella delicatula as evidenced by abrogation of rotenone-induced motor deficits, oxidative dysfunctions, and neurotoxicity in mice.

Authors:  Girish Chandran
Journal:  Cell Mol Neurobiol       Date:  2013-07-19       Impact factor: 5.046

2.  Potential Mechanisms Responsible for the Antinephrolithic Effects of an Aqueous Extract of Fructus Aurantii.

Authors:  Xiaoran Li; Qiang Liang; Yunji Sun; Long Diao; Ze Qin; Wei Wang; Jianzhong Lu; Shengjun Fu; Baoliang Ma; Zhongjin Yue
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-15       Impact factor: 2.629

Review 3.  Dietary Plants for the Prevention and Management of Kidney Stones: Preclinical and Clinical Evidence and Molecular Mechanisms.

Authors:  Mina Cheraghi Nirumand; Marziyeh Hajialyani; Roja Rahimi; Mohammad Hosein Farzaei; Stéphane Zingue; Seyed Mohammad Nabavi; Anupam Bishayee
Journal:  Int J Mol Sci       Date:  2018-03-07       Impact factor: 5.923

Review 4.  Plants Used in Mexican Traditional Medicine for the Management of Urolithiasis: A Review of Preclinical Evidence, Bioactive Compounds, and Molecular Mechanisms.

Authors:  Delia Sansores-España; Alfredo Geovanny Pech-Aguilar; Karol Guadalupe Cua-Pech; Isabel Medina-Vera; Martha Guevara-Cruz; Ana Ligia Gutiérrez-Solis; Juan G Reyes-García; Azalia Avila-Nava
Journal:  Molecules       Date:  2022-03-21       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.